Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mismatch Repair

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Genital Herpes

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...

Preventive Healthcare Services

Preventive Healthcare Services

Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:

Sexually Transmitted Infections

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...

Healthcare Associated Infections II: Preventive Measures

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Understanding the primary-secondary care interface and its impact on workforce sustainability: a realist review protocol.

BJGP open·2026

Same author

Development and Validation of the Primary Care Needs Assessment (PCNA) Questionnaire: A Participatory Multidimensional Approach to Identifying Health Needs.

Healthcare (Basel, Switzerland)·2026

Same author

Burnout and patient safety: navigating between exaggerated evidence and warranted assertability.

Frontiers in psychology·2026

Same author

Competing Theories on Global and Regional Vaccine Inequities: A Scoping Literature Review Within the Context of the COVID-19 Pandemic.

Vaccines·2025

Same author

Understanding the contextual and causal factors shaping the work of receptionists in general practice: a realist review protocol.

BMJ open·2025

Same author

When I say … workforce sustainability.

Medical education·2025

Search research articles

Related Experiment Video

Updated: May 29, 2026

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

Human papillomavirus and cervical screening: misconceptions undermine adherence.

Efharis Panagopoulou¹, Ourania Giata, Anthony Montgomery

¹Department of Biological Sciences and Preventive Medicine, Medical School, Aristotle University Thessaloniki, Macedonia, Greece. efharis@the.forthnet.gr

American Journal of Health Promotion : AJHP

|September 2, 2011

Summary

Misconceptions about the human papillomavirus (HPV) vaccine can decrease cervical cancer screening adherence. This highlights the need for clear public health messaging to ensure continued screening alongside vaccination efforts.

More Related Videos

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

Related Experiment Videos

Last Updated: May 29, 2026

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

Area of Science:

Oncology
Public Health
Epidemiology

Background:

Cervical cancer incidence is significantly reduced by prophylactic vaccination programs and cervical screening.
The human papillomavirus (HPV) vaccine is a key component of global cervical cancer prevention strategies.

Purpose of the Study:

To test the hypothesis that HPV vaccination may negatively impact adherence to cervical screening.
To investigate if public misconceptions about the HPV vaccine eliminating the need for screening affect screening behaviors.

Main Methods:

A postal survey was conducted using a stratified random sample of 1000 students (500 medical, 500 nonmedical) at the Aristotle University of Thessaloniki.
A questionnaire assessed demographic characteristics, cervical screening adherence, and HPV awareness and attitudes.
Logistic regression analysis examined the impact of HPV awareness and vaccination attitudes on Papanicolaou screening adherence.

Main Results:

Students who believed the HPV vaccine negated the need for Papanicolaou (Pap) tests were significantly less likely to adhere to screening (adjusted odds ratio, 1.89).
This effect was more pronounced in nonmedical students (adjusted odds ratio, 3.05).
The findings indicate a statistically significant association between vaccine-related misconceptions and reduced screening adherence.

Conclusions:

Misconceptions regarding HPV vaccination can adversely affect crucial preventive health behaviors.
Reduced adherence to cervical screening due to these misconceptions can lower the probability of early cervical cancer diagnosis.
Clear communication is essential to ensure that vaccination does not replace, but complements, regular cervical screening programs.